Pamela L Brownlie, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5814 Highway 348, Olathe, CO 81425 Phone: 970-323-5400 Fax: 970-323-9090 |
Laura Chevreaux, PT, WCC Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 885 S Highway 50 Business Loop, Olathe, CO 81425 Phone: 530-906-2232 |
Joelle Grossman, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 750 8th St, Olathe, CO 81425 Phone: 970-323-5504 |
News Archive
Findings from a new Geisel-led study, published in the Journal of General Internal Medicine, reveal that there is substantial variation across different regions of the country in the intensity of fracture-associated drug (FAD) use among long-term care facility residents, and that areas with greater use of these prescription drugs experience higher hip fracture rates.
A somewhat mysterious soft tissue found in the fetus during early development in the womb plays a pivotal role in the formation of mature beta cells the sole source of the body's insulin. This discovery, made by scientists at University of California, San Francisco (UCSF) and Texas A&M University, may lead to new ways of addressing Type 1 and Type 2 diabetes.
Bausch + Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced that its next generation sub-micron gel formulation of loteprednol etabonate was statistically superior to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery by study day eight, the primary endpoints in the first Phase 3, multi-center, double-masked, vehicle-controlled, parallel-group study.
Veloxis Pharmaceuticals A/S announced today that the U.S. Food and Drug Administration has informed Veloxis of the tentative approval of Envarsus XR. FDA stated that the final approval of Envarsus XR will be delayed until expiration of the exclusivity period for Astellas' Astagraf XL.
› Verified 7 days ago